BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 1102620)

  • 21. Classical pathway complement activation in association with paraproteinaemia.
    Naish PF; Collins C; Barratt J
    Immunology; 1977 Oct; 33(4):517-21. PubMed ID: 924520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of the complement-fixing factor.
    Carruthers JA; Ewins AR
    Clin Exp Immunol; 1978 Jan; 31(1):38-44. PubMed ID: 346270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic phenomena in herpes gestationis.
    Jabłońska S; Chorzelski TP; Maciejowska E; Jarzabek-Chorzelska M; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):769-74. PubMed ID: 373687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes gestationis. Immunopathology and characterization of the HG factor.
    Katz SI; Hertz KC; Yaoita H
    J Clin Invest; 1976 Jun; 57(6):1434-41. PubMed ID: 819458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deposition of the membrane attack complex of complement in bullous pemphigoid.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes gestationis associated with the C3 nephritic factor.
    Grimwood R; Arroyave CM; Weston WL; Aeling JL
    Arch Dermatol; 1980 Sep; 116(9):1045-7. PubMed ID: 6998378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 28. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement as an essential factor for indirect immunofluorescence in cases of pemphigoid.
    Bockendahl H; Remy W; Stüttgen G; Petersen G
    Acta Derm Venereol; 1977; 57(3):233-5. PubMed ID: 71828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized chronic pemphigoid. Report of a case, review of the literature and discussion of the relationship with cicatricial pemphigoid.
    Nieboer C; Roeleveld CG; Kalsbeek GL
    Dermatologica; 1978; 156(1):24-33. PubMed ID: 338387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathologic study of herpes gestationis in mother and infant.
    Katz A; Minto JO; Toole JW; Medwidsky W
    Arch Dermatol; 1977 Aug; 113(8):1069-72. PubMed ID: 329771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
    Velosa J; Miller K; Michael AF
    Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunopathological study of bullous pemphigoid, cicatricial pemphigoid and herpes gestationis].
    Barthélémy H; Ohrt C; Thivolet J
    Ann Dermatol Venereol; 1985; 112(5):403-10. PubMed ID: 3898966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parapemphigus and variants; clinical and immunological aspects].
    Laeijendecker R; Oranje AP; van Joost T
    Ned Tijdschr Geneeskd; 1989 Sep; 133(35):1741-4. PubMed ID: 2677789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunological study of patients with bullous pemphigoid.
    Hovmark A; Asbrink E
    Acta Derm Venereol; 1982; 62(3):201-4. PubMed ID: 6179358
    [No Abstract]   [Full Text] [Related]  

  • 40. A typical case of pemphigoid gestationis with a unique pattern of intercellular immunofluorescence.
    Vaughan Jones SA; Bhogal BS; Black MM; Clement M; Hashimoto T; Nishikawa T
    Br J Dermatol; 1997 Feb; 136(2):245-8. PubMed ID: 9068742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.